Diazoxide	B:C0012022
prevents	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
mitochondrial	O
damage	I:C1096176
,	O
leading	O
to	O
anti-hypertrophic	O
effects	I:C0243095
.	O

Diazoxide	O
prevents	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
mitochondrial	O
damage	I:C1096176
,	O
leading	O
to	O
anti-hypertrophic	O
effects	I:C0243095
.	O

Diazoxide	O
prevents	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
mitochondrial	B:C1096176
damage	I:C1096176
,	O
leading	O
to	O
anti-hypertrophic	O
effects	I:C0243095
.	O

Diazoxide	O
prevents	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
mitochondrial	O
damage	I:C1096176
,	O
leading	O
to	O
anti-hypertrophic	B:C0243095
effects	I:C0243095
.	O

Pathological	O
cardiac	B:C1383860
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	O
thickening	O
or	O
chamber	O
enlargement	O
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

Pathological	O
cardiac	O
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	B:C0446987
thickening	O
or	O
chamber	O
enlargement	O
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

Pathological	O
cardiac	O
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	O
thickening	B:C0205400
or	O
chamber	O
enlargement	O
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

Pathological	O
cardiac	O
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	O
thickening	O
or	O
chamber	B:C0729936
enlargement	O
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

Pathological	O
cardiac	O
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	O
thickening	O
or	O
chamber	O
enlargement	B:C0020564
of	O
the	O
heart	O
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

Pathological	O
cardiac	O
hypertrophy	I:C1383860
is	O
characterized	O
by	O
wall	O
thickening	O
or	O
chamber	O
enlargement	O
of	O
the	O
heart	B:C0018787
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O

This	O
condition	O
will	O
,	O
initially	O
,	O
improve	B:C0184511
the	O
organ	O
contractile	O
function	I:C1258017
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	O
and	O
oxidative	O
stress	I:C0242606
.	O

This	O
condition	O
will	O
,	O
initially	O
,	O
improve	O
the	O
organ	B:C0178784
contractile	O
function	I:C1258017
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	O
and	O
oxidative	O
stress	I:C0242606
.	O

This	O
condition	O
will	O
,	O
initially	O
,	O
improve	O
the	O
organ	O
contractile	B:C1258017
function	I:C1258017
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	O
and	O
oxidative	O
stress	I:C0242606
.	O

This	O
condition	O
will	O
,	O
initially	O
,	O
improve	O
the	O
organ	O
contractile	O
function	I:C1258017
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	B:C0026237
and	O
oxidative	O
stress	I:C0242606
.	O

This	O
condition	O
will	O
,	O
initially	O
,	O
improve	O
the	O
organ	O
contractile	O
function	I:C1258017
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	O
and	O
oxidative	B:C0242606
stress	I:C0242606
.	O

Mitochondrial	B:C0764439
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	O
)	O
modulate	O
the	O
redox	O
status	I:C0030012
of	O
the	O
cell	O
and	O
protect	O
against	O
several	O
cardiac	O
insults	O
.	O

Mitochondrial	O
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	B:C0764439
)	O
modulate	O
the	O
redox	O
status	I:C0030012
of	O
the	O
cell	O
and	O
protect	O
against	O
several	O
cardiac	O
insults	O
.	O

Mitochondrial	O
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	O
)	O
modulate	B:C0443264
the	O
redox	O
status	I:C0030012
of	O
the	O
cell	O
and	O
protect	O
against	O
several	O
cardiac	O
insults	O
.	O

Mitochondrial	O
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	O
)	O
modulate	O
the	O
redox	B:C0030012
status	I:C0030012
of	O
the	O
cell	O
and	O
protect	O
against	O
several	O
cardiac	O
insults	O
.	O

Mitochondrial	O
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	O
)	O
modulate	O
the	O
redox	O
status	I:C0030012
of	O
the	O
cell	B:C0007634
and	O
protect	O
against	O
several	O
cardiac	O
insults	O
.	O

Mitochondrial	O
ATP	I:C0764439
-	I:C0764439
sensitive	I:C0764439
K(+	I:C0764439
)	I:C0764439
channels	I:C0764439
(	O
mitoKATP	O
)	O
modulate	O
the	O
redox	O
status	I:C0030012
of	O
the	O
cell	O
and	O
protect	O
against	O
several	O
cardiac	B:C0018787
insults	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	B:C0764439
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	B:C1882151
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	B:C0012022
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	B:C0022245
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	B:C1383860
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	B:C1515655
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	B:C0162772
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	B:C0026237
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	B:C0596235
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
.	O

Here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mitoKATP	O
opening	O
(	O
using	O
diazoxide	O
)	O
will	O
avoid	O
isoproterenol	O
-	O
induced	O
cardiac	O
hypertrophy	I:C1383860
in	O
vivo	I:C1515655
by	O
decreasing	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
ROS	I:C0162772
)	O
production	O
and	O
mitochondrial	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	B:C0038999
.	O

To	O
induce	O
cardiac	B:C1383860
hypertrophy	I:C1383860
,	O
Swiss	O
mice	I:C0162416
were	O
treated	O
intraperitoneally	O
with	O
isoproterenol	O
(	O
30	O
mg	O
/	O
kg/	O
day	O
)	O
for	O
8	O
days	O
.	O

To	O
induce	O
cardiac	O
hypertrophy	I:C1383860
,	O
Swiss	B:C0162416
mice	I:C0162416
were	O
treated	O
intraperitoneally	O
with	O
isoproterenol	O
(	O
30	O
mg	O
/	O
kg/	O
day	O
)	O
for	O
8	O
days	O
.	O

To	O
induce	O
cardiac	O
hypertrophy	I:C1383860
,	O
Swiss	O
mice	I:C0162416
were	O
treated	O
intraperitoneally	B:C0442120
with	O
isoproterenol	O
(	O
30	O
mg	O
/	O
kg/	O
day	O
)	O
for	O
8	O
days	O
.	O

To	O
induce	O
cardiac	O
hypertrophy	I:C1383860
,	O
Swiss	O
mice	I:C0162416
were	O
treated	O
intraperitoneally	O
with	O
isoproterenol	B:C0022245
(	O
30	O
mg	O
/	O
kg/	O
day	O
)	O
for	O
8	O
days	O
.	O

Diazoxide	B:C0012022
(	O
5	O
mg	O
/kg/	O
day	O
)	O
was	O
used	O
to	O
open	O
mitoKATP	O
and	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
administrated	O
as	O
a	O
mitoKATP	O
blocker	O
.	O

Diazoxide	O
(	O
5	O
mg	O
/kg/	O
day	O
)	O
was	O
used	O
to	O
open	O
mitoKATP	B:C0764439
and	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
administrated	O
as	O
a	O
mitoKATP	O
blocker	O
.	O

Diazoxide	O
(	O
5	O
mg	O
/kg/	O
day	O
)	O
was	O
used	O
to	O
open	O
mitoKATP	O
and	O
5	B:C0098450
-	I:C0098450
hydroxydecanoate	I:C0098450
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
administrated	O
as	O
a	O
mitoKATP	O
blocker	O
.	O

Diazoxide	O
(	O
5	O
mg	O
/kg/	O
day	O
)	O
was	O
used	O
to	O
open	O
mitoKATP	O
and	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
administrated	O
as	O
a	O
mitoKATP	B:C0764439
blocker	O
.	O

Isoproterenol	B:C0022245
-	O
treated	O
mice	O
had	O
elevated	O
heart	O
weight	O
/	O
tibia	O
length	O
ratios	O
and	O
increased	O
myocyte	O
cross-sectional	O
areas	I:C0243095
.	O

Isoproterenol	O
-	O
treated	O
mice	B:C0025929
had	O
elevated	O
heart	O
weight	O
/	O
tibia	O
length	O
ratios	O
and	O
increased	O
myocyte	O
cross-sectional	O
areas	I:C0243095
.	O

Isoproterenol	O
-	O
treated	O
mice	O
had	O
elevated	O
heart	B:C0018787
weight	O
/	O
tibia	O
length	O
ratios	O
and	O
increased	O
myocyte	O
cross-sectional	O
areas	I:C0243095
.	O

Isoproterenol	O
-	O
treated	O
mice	O
had	O
elevated	O
heart	O
weight	O
/	O
tibia	B:C1279118
length	O
ratios	O
and	O
increased	O
myocyte	O
cross-sectional	O
areas	I:C0243095
.	O

Isoproterenol	O
-	O
treated	O
mice	O
had	O
elevated	O
heart	O
weight	O
/	O
tibia	O
length	O
ratios	O
and	O
increased	O
myocyte	B:C0225828
cross-sectional	O
areas	I:C0243095
.	O

Isoproterenol	O
-	O
treated	O
mice	O
had	O
elevated	O
heart	O
weight	O
/	O
tibia	O
length	O
ratios	O
and	O
increased	O
myocyte	O
cross-sectional	B:C0243095
areas	I:C0243095
.	O

Additionally	O
,	O
hypertrophic	O
hearts	B:C0018787
produced	O
higher	O
levels	O
of	O
H2O2	O
and	O
had	O
lower	O
glutathione	O
peroxidase	I:C1151528
activity	I:C1151528
.	O

Additionally	O
,	O
hypertrophic	O
hearts	O
produced	O
higher	O
levels	O
of	O
H2O2	B:C0020281
and	O
had	O
lower	O
glutathione	O
peroxidase	I:C1151528
activity	I:C1151528
.	O

Additionally	O
,	O
hypertrophic	O
hearts	O
produced	O
higher	O
levels	O
of	O
H2O2	O
and	O
had	O
lower	O
glutathione	B:C1151528
peroxidase	I:C1151528
activity	I:C1151528
.	O

In	O
contrast	O
,	O
mitoKATP	B:C0764439
opening	O
with	O
diazoxide	O
blocked	O
all	O
isoproterenol	O
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

In	O
contrast	O
,	O
mitoKATP	O
opening	B:C1882151
with	O
diazoxide	O
blocked	O
all	O
isoproterenol	O
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

In	O
contrast	O
,	O
mitoKATP	O
opening	O
with	O
diazoxide	B:C0012022
blocked	O
all	O
isoproterenol	O
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

In	O
contrast	O
,	O
mitoKATP	O
opening	O
with	O
diazoxide	O
blocked	O
all	O
isoproterenol	B:C0022245
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

In	O
contrast	O
,	O
mitoKATP	O
opening	O
with	O
diazoxide	O
blocked	O
all	O
isoproterenol	O
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	B:C0098450
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

Isolated	O
mitochondria	B:C0026237
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	B:C0022245
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	B:C0018787
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	B:C0596235
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	B:C0038999
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	B:C0908146
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	O
.	O

Isolated	O
mitochondria	O
from	O
Isoproterenol	O
-	O
induced	O
hypertrophic	O
hearts	O
had	O
increased	O
susceptibility	O
to	O
Ca(	O
2	I:C0596235
+	I:C0596235
)	I:C0596235
-	O
induced	O
swelling	O
secondary	O
to	O
mitochondrial	O
permeability	I:C0908146
transition	I:C0908146
pore	I:C0908146
opening	B:C1882151
.	O

MitokATP	B:C0764439
opening	O
was	O
accompanied	O
by	O
lower	O
Ca(	O
2+	I:C0596235
)	I:C0596235
-	O
induced	O
mitochondrial	O
swelling	I:C0026244
,	O
an	O
effect	O
blocked	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

MitokATP	O
opening	B:C1882151
was	O
accompanied	O
by	O
lower	O
Ca(	O
2+	I:C0596235
)	I:C0596235
-	O
induced	O
mitochondrial	O
swelling	I:C0026244
,	O
an	O
effect	O
blocked	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

MitokATP	O
opening	O
was	O
accompanied	O
by	O
lower	O
Ca(	B:C0596235
2+	I:C0596235
)	I:C0596235
-	O
induced	O
mitochondrial	O
swelling	I:C0026244
,	O
an	O
effect	O
blocked	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

MitokATP	O
opening	O
was	O
accompanied	O
by	O
lower	O
Ca(	O
2+	I:C0596235
)	I:C0596235
-	O
induced	O
mitochondrial	B:C0026244
swelling	I:C0026244
,	O
an	O
effect	O
blocked	O
by	O
5	O
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

MitokATP	O
opening	O
was	O
accompanied	O
by	O
lower	O
Ca(	O
2+	I:C0596235
)	I:C0596235
-	O
induced	O
mitochondrial	O
swelling	I:C0026244
,	O
an	O
effect	O
blocked	O
by	O
5	B:C0098450
-	I:C0098450
hydroxydecanoate	I:C0098450
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	B:C0764439
opening	O
negatively	O
regulates	O
cardiac	O
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	O
damage	I:C1096176
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	O
opening	B:C1882151
negatively	O
regulates	O
cardiac	O
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	O
damage	I:C1096176
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	O
opening	O
negatively	B:C0205160
regulates	O
cardiac	O
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	O
damage	I:C1096176
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	O
opening	O
negatively	O
regulates	B:C1327622
cardiac	O
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	O
damage	I:C1096176
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	O
opening	O
negatively	O
regulates	O
cardiac	B:C1383860
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	O
damage	I:C1096176
.	O

Our	O
results	O
suggest	O
that	O
mitoKATP	O
opening	O
negatively	O
regulates	O
cardiac	O
hypertrophy	I:C1383860
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	B:C1096176
damage	I:C1096176
.	O

